TAK-020 |
Catalog No.GC64120 |
TAK-020 is a covalent Btk inhibitor, which becomes the clinical candidate.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1627603-21-7
Sample solution is provided at 25 µL, 10mM.
TAK-020 is a covalent Btk inhibitor, which becomes the clinical candidate.
[1]. Sabat M, et al. Discovery of the Bruton’s Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one, by Fragment-Based Drug Design. J Med Chem. 2021 Sep 9;64(17):12893-12902.
Average Rating: 5
(Based on Reviews and 14 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *